These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


566 related items for PubMed ID: 8944348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacoeconomic analysis of oral antifungal therapies used to treat dermatophyte onychomycosis of the toenails. A US analysis.
    Gupta AK.
    Pharmacoeconomics; 1998 Feb; 13(2):243-56. PubMed ID: 10178650
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cost effectiveness of continuous terbinafine compared with intermittent itraconazole in the treatment of dermatophyte toenail onychomycosis: an analysis of based on results from the L.I.ON. study. Lamisil versus Itraconazole in Onychomycosis.
    Jansen R, Redekop WK, Rutten FF.
    Pharmacoeconomics; 2001 Feb; 19(4):401-10. PubMed ID: 11383756
    [Abstract] [Full Text] [Related]

  • 7. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK, Konnikov N, Lynde CW.
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK, Lynde CW, Konnikov N.
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [Abstract] [Full Text] [Related]

  • 11. Pharmacoeconomic analysis of oral therapies for onychomycosis: a US model.
    Marchetti A, Piech CT, McGhan WF, Neugut AI, Smith BT.
    Clin Ther; 1996 Mar; 18(4):757-77; discussion 702. PubMed ID: 8879902
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An independent comparison of terbinafine and itraconazole in the treatment of toenail onychomycosis.
    Cohen AD, Medvesovsky E, Shalev R, Biton A, Chetov T, Naimer S, Shai A, Vardy DA.
    J Dermatolog Treat; 2003 Dec; 14(4):237-42. PubMed ID: 14660272
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK, Gregurek-Novak T.
    Dermatology; 2001 Dec; 202(3):235-8. PubMed ID: 11385230
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Satisfaction with onychomycosis treatment. Pulse versus continuous dosing.
    Warshaw EM, Bowman T, Bodman MA, Kim JJ, Silva S, Mathias SD.
    J Am Podiatr Med Assoc; 2003 Dec; 93(5):373-9. PubMed ID: 13130084
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recurrences of dermatophyte toenail onychomycosis during long-term follow-up after successful treatments with mono- and combined therapy of terbinafine and itraconazole.
    Gupta AK, Cooper EA, Paquet M.
    J Cutan Med Surg; 2013 Dec; 17(3):201-6. PubMed ID: 23673304
    [Abstract] [Full Text] [Related]

  • 20. The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
    Gupta AK, Stec N, Bamimore MA, Foley KA, Shear NH, Piguet V.
    J Eur Acad Dermatol Venereol; 2020 Mar; 34(3):580-588. PubMed ID: 31746067
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.